Related Experiment Video
Updated: Sep 24, 2026

Using the Threat Probability Task to Assess Anxiety and Fear During Uncertain and Certain Threat
Published on: September 12, 2014
Diminished Positive Affect as an Understudied Feature of Nicotine Withdrawal: Development and Validation of a Short
Yanyan Sheng1, Yantao Zuo2, Norka E Rabinovich3
1The University of Chicago, Committee on Quantitative Methods.
Introduction:
Given the burgeoning evidence that low positive affect (PA) and anhedonia are important smoking withdrawal symptoms, we added the PA/Friendly items of the Profile of Mood States (POMS) alongside established withdrawal items from the Shiffman-Jarvik Withdrawal Questionnaire (SJWQ) to identify the best subsets of items for predicting smoking relapse. The Short Withdrawal Symptom Scale (SWiSS) was generated from these selected items.
Methods:
Secondary data analysis was conducted with four randomized clinical trials of cessation-seeking smokers (N = 333) who maintained abstinence for 31-67 days. SWiSS items were selected from the POMS and the SJWQ using a procedure encompassing longitudinal trajectory preservation, multilevel factor analysis, psychometric evaluation, and predictive validation. Logistic and survival models were used to predict smoking outcomes from growth parameters of withdrawal symptoms across days 3-31 post-quit.
Results:
The original 91-item pool was reduced to 28 items, forming five within-person factors: positive affect/friendliness, negative affect, fatigue/arousal, depression, and craving, plus one appetite item. These SWiSS factors demonstrated strong reliability and clean factor structure. Predictive validation results matched or exceeded original scales. Higher early post-quit PA/friendliness was protective, whereas early craving and fatigue predicted greater relapse risk. Notably, PA was the only domain for which both early level and rate of recovery independently predicted cessation outcomes.
Conclusion:
The SWiSS is a relatively brief, psychometrically robust measure that preserves relapse-predicting information about withdrawal dynamics. Its development highlights low PA as a significant and understudied predictor of relapse risk, and supports the inclusion of PA items in smoking withdrawal measures.
More Related Videos
Related Concept Videos
Drug Dependence
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Depressants: Alcohol and Nicotine
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Traits, Mood, and Subjective Wellbeing
Neuroticism and Emotional...
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...

